These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1970755)

  • 1. The beta-adrenergic pathway in the failing human heart: implications for inotropic therapy.
    Feldman AM; Bristow MR
    Cardiology; 1990; 77 Suppl 1():1-32. PubMed ID: 1970755
    [No Abstract]   [Full Text] [Related]  

  • 2. Rationale for beta-adrenergic blocking drugs in cardiomyopathy.
    Fowler MB; Bristow MR
    Am J Cardiol; 1985 Apr; 55(10):120D-124D. PubMed ID: 2859789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of the beta-adrenergic signaling pathway in human heart failure.
    Hamdani N; Linke WA
    Curr Pharm Biotechnol; 2012 Oct; 13(13):2522-31. PubMed ID: 22280427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The paradox of beta-adrenergic blockade for the management of congestive heart failure.
    Eichhorn EJ
    Am J Med; 1992 May; 92(5):527-38. PubMed ID: 1349791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How do beta-blockers improve ventricular function in patients with congestive heart failure?
    Barry WH; Gilbert EM
    Circulation; 2003 May; 107(19):2395-7. PubMed ID: 12756189
    [No Abstract]   [Full Text] [Related]  

  • 6. [Importance of beta 2-adrenergic receptors in heart failure].
    Brodde OE; Daul A; Michel MC; Zerkowski HR
    Z Kardiol; 1992; 81 Suppl 4():71-8. PubMed ID: 1363262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical pharmacology of anti-arrhythmia agents. III. Drugs blocking beta adrenergic receptors].
    Witkowska M
    Kardiol Pol; 1982; 25(2):147-61. PubMed ID: 6125621
    [No Abstract]   [Full Text] [Related]  

  • 8. Adrenergic receptors: new concepts and implications for cardiovascular therapeutics.
    Colucci WS; Braunwald E
    Cardiovasc Clin; 1984; 14(3):39-59. PubMed ID: 6144390
    [No Abstract]   [Full Text] [Related]  

  • 9. Inotropic drugs for treatment of the failing heart.
    Maskin CS; Le Jemtel TH; Sonnenblick EH
    Cardiovasc Clin; 1984; 14(3):1-17. PubMed ID: 6327040
    [No Abstract]   [Full Text] [Related]  

  • 10. [Action of cardiac glycosides and the process of adrenergic mediation (a review of the literature)].
    Frantsuzova SB
    Farmakol Toksikol; 1977; 40(6):733-45. PubMed ID: 23310
    [No Abstract]   [Full Text] [Related]  

  • 11. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
    Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
    J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sympathetic nervous system in chronic heart failure.
    Joseph J; Gilbert EM
    Prog Cardiovasc Dis; 1998; 41(1 Suppl 1):9-16. PubMed ID: 9715818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-adrenergic pathways in nonfailing and failing human ventricular myocardium.
    Bristow MR; Hershberger RE; Port JD; Gilbert EM; Sandoval A; Rasmussen R; Cates AE; Feldman AM
    Circulation; 1990 Aug; 82(2 Suppl):I12-25. PubMed ID: 2164894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adrenergic activation in heart failure: blockade or rebalance?].
    Emdin M; Vergaro G; Giannoni A; Passino C
    G Ital Cardiol (Rome); 2010 Mar; 11(3):229-32. PubMed ID: 20550063
    [No Abstract]   [Full Text] [Related]  

  • 15. [How is catecholamine therapy carried out in heart failure?].
    Reek S
    Dtsch Med Wochenschr; 2002 Oct; 127(40):2087-8. PubMed ID: 12373645
    [No Abstract]   [Full Text] [Related]  

  • 16. Targeting Adrenergic Receptors in Metabolic Therapies for Heart Failure.
    Perez DM
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-adrenoceptor polymorphisms and heart failure.
    Lohse MJ
    Trends Mol Med; 2004 Feb; 10(2):55-8. PubMed ID: 15106619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in cardiac myocyte function by biological effects of medical therapy: a new concept in the treatment of heart failure.
    Bristow MR; Gilbert EM
    Eur Heart J; 1995 Jul; 16 Suppl F():20-31. PubMed ID: 8521881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-blocking agents and positive inotropic agents in the therapy of chronic heart failure.
    Erdmann E; Schwinger R; Böhm M
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S138-44. PubMed ID: 11527118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The beta-adrenergic receptor-adenylate cyclase complex as a target for therapeutic intervention in heart failure.
    Bristow MR; Port JD; Hershberger RE; Gilbert EM; Feldman AM
    Eur Heart J; 1989 Jun; 10 Suppl B():45-54. PubMed ID: 2572420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.